MedTrace Logo

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients

NCT03134261 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-05-05

No results posted yet for this study

Summary

An improved diagnosis of bone metastases in prostate cancer patients can have a significant impact on treatment strategy and probably survival as well.

The primary purpose of the project is to determine the diagnostic accuracy of bone SPECT-CT, choline-PET-CT, PSMA-PET-CT, NaF-PET-CT and Whole-body MRI in the diagnosis of bone metastases in prostate cancer patients.

Conditions

  • Prostate Cancer Metastatic to Bone

Interventions

DIAGNOSTIC_TEST

WB-MRI

scanning methods

DIAGNOSTIC_TEST

SPECT-CT

scanning methods

DIAGNOSTIC_TEST

Cholin-PET-CT

scanning methods

DIAGNOSTIC_TEST

PSMA-PET-CT

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Henrik S. Thomsen, Professor · Department of Radiology

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03134261 on ClinicalTrials.gov